Studies in non-human primates (NHPs) have made substantial contributions to our understanding of HIV-1 pathogenesis and vaccine immunology. The high overall genetic homology between humans and rhesus macaques, coupled with the phenotypic conservation of lymphocyte populations, highlights the utility of NHPs for evaluating clinical vaccine candidates. Core B will be responsible for the planning, design and execution of non-human primate (NHP) experiments described in Projects 1-4 of this HIVRAD P01. Additionally, the Core will support the dissemination of NHP cells, plasma, DNA and cloned antibodies to Project 1-4 as required to meet the overall goals ofthe HIVRAD consortia. In addition, the Core will support sample distribution to relevant collaboration partners, to maximize the information gained from these studies.
In Aim 1, Core B will provide the necessary logistical support for the NHP experiments such as complete the appropriate papenwork for conducting NHP studies at the Astrid Fagraeus Laboratory (AFL) in Stockholm, plan the purchase and transport ofthe rhesus macaques and their housing organization. Core B will also serve as a communication link between Projects 1-4 and the NIH for all issues related to the NHP immunogenicity studies to support the efforts of all Projects within the proposal.
In Aim 2, Core B will oversee the execution ofthe NHP experiments to be conducted in this proposal, including ensuring that detailed schedules for inoculations and sample collection exist as well as robust processes to maintain the NHP biobank.
In Aim 3, Core B will work with the personnel at the AFL to refine methods for B cell sampling and analysis of humoral immune responses. The proximity between the AFL and the Karisson Hedestam laboratory means that vaccine components can be prepared immediately before animal inoculation and hand-delivered directly to the AFL. Similariy, transfer of cells from the animals back to the laboratory is performed by personnel in the Karlsson Hedestam laboratory who collect PBMCs, bone marrow, lymph node biopsies directly from the AFL for direct analysis or freezing back in the Karisson Hedestam laboratory. These processes are of critical importance forthe success ofthe proposed HIVRAD project.

Public Health Relevance

The major objective of Core B is to conduct the non-human primate experiments required to address the questions outlined in Projects 1-4 of this HIVRAD application. The ultimate aims of these studies are to define, at a high resolution, Env vaccine-elicited B cell responses and to use this information to design new generation Env vaccine candidates to more successfully elicit broadly protective B cell responses against HlV-1

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
1P01AI104722-01A1
Application #
8680627
Study Section
Special Emphasis Panel (ZAI1-KP-A (J1))
Project Start
Project End
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
1
Fiscal Year
2014
Total Cost
$71,216
Indirect Cost
$20,631
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Sheng, Zizhang; Schramm, Chaim A; Connors, Mark et al. (2016) Effects of Darwinian Selection and Mutability on Rate of Broadly Neutralizing Antibody Evolution during HIV-1 Infection. PLoS Comput Biol 12:e1004940
Guenaga, Javier; Dubrovskaya, Viktoriya; de Val, Natalia et al. (2016) Structure-Guided Redesign Increases the Propensity of HIV Env To Generate Highly Stable Soluble Trimers. J Virol 90:2806-17
Bonsignori, Mattia; Zhou, Tongqing; Sheng, Zizhang et al. (2016) Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody. Cell 165:449-63
Tian, Ming; Cheng, Cheng; Chen, Xuejun et al. (2016) Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires. Cell 166:1471-1484.e18
Ingale, Jidnyasa; Stano, Armando; Guenaga, Javier et al. (2016) High-Density Array of Well-Ordered HIV-1 Spikes on Synthetic Liposomal Nanoparticles Efficiently Activate B Cells. Cell Rep 15:1986-99
Chen, Yajing; Wilson, Richard; O'Dell, Sijy et al. (2016) An HIV-1 Env-Antibody Complex Focuses Antibody Responses to Conserved Neutralizing Epitopes. J Immunol 197:3982-3998
Wang, Yimeng; Sundling, Christopher; Wilson, Richard et al. (2016) High-Resolution Longitudinal Study of HIV-1 Env Vaccine-Elicited B Cell Responses to the Virus Primary Receptor Binding Site Reveals Affinity Maturation and Clonal Persistence. J Immunol 196:3729-43
Schramm, Chaim A; Sheng, Zizhang; Zhang, Zhenhai et al. (2016) SONAR: A High-Throughput Pipeline for Inferring Antibody Ontogenies from Longitudinal Sequencing of B Cell Transcripts. Front Immunol 7:372
Dai, Kaifan; Khan, Salar N; Wang, Yimeng et al. (2016) HIV-1 Vaccine-elicited Antibodies Reverted to Their Inferred Naive Germline Reveal Associations between Binding Affinity and in vivo Activation. Sci Rep 6:20987
Phad, Ganesh E; Vázquez Bernat, Néstor; Feng, Yu et al. (2015) Diverse antibody genetic and recognition properties revealed following HIV-1 envelope glycoprotein immunization. J Immunol 194:5903-14

Showing the most recent 10 out of 17 publications